Maven Income and Growth VCT 4 (MAV4) Competitors GBX 54 -1.00 (-1.82%) As of 06/12/2025 10:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock MAV4 vs. PCFC, EAT, HHI, JPS, WPCT, NCYF, BGHS, GSEO, STS, and BBHShould you be buying Maven Income and Growth VCT 4 stock or one of its competitors? The main competitors of Maven Income and Growth VCT 4 include Polar Capital Global Financials Trust (PCFC), European Assets Trust (EAT), Henderson High Income Trust (HHI), JPMorgan Japan Small Cap Growth & Income plc (JPS.L) (JPS), Woodford Patient Capital Trust (WPCT), CQS New City High Yield (NCYF), Boussard & Gavaudan GBP (BGHS), VH Global Sustainable Energy Opportunities (GSEO), STS Global Income & Growth Trust (STS), and Bellevue Healthcare (BBH). These companies are all part of the "asset management" industry. Maven Income and Growth VCT 4 vs. Its Competitors Polar Capital Global Financials Trust European Assets Trust Henderson High Income Trust JPMorgan Japan Small Cap Growth & Income plc (JPS.L) Woodford Patient Capital Trust CQS New City High Yield Boussard & Gavaudan GBP VH Global Sustainable Energy Opportunities STS Global Income & Growth Trust Bellevue Healthcare Maven Income and Growth VCT 4 (LON:MAV4) and Polar Capital Global Financials Trust (LON:PCFC) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends. Does the media favor MAV4 or PCFC? In the previous week, Maven Income and Growth VCT 4's average media sentiment score of 0.00 equaled Polar Capital Global Financials Trust'saverage media sentiment score. Company Overall Sentiment Maven Income and Growth VCT 4 Neutral Polar Capital Global Financials Trust Neutral Does the MarketBeat Community prefer MAV4 or PCFC? Maven Income and Growth VCT 4 received 71 more outperform votes than Polar Capital Global Financials Trust when rated by MarketBeat users. CompanyUnderperformOutperformMaven Income and Growth VCT 4Outperform Votes7167.62% Underperform Votes3432.38% Polar Capital Global Financials TrustN/AN/A Which has stronger earnings & valuation, MAV4 or PCFC? Maven Income and Growth VCT 4 has higher earnings, but lower revenue than Polar Capital Global Financials Trust. Polar Capital Global Financials Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaven Income and Growth VCT 4£4.20M18.89£1.33M£0.9159.55Polar Capital Global Financials Trust£70.33M0.00N/A£49.50N/A Is MAV4 or PCFC more profitable? Maven Income and Growth VCT 4 has a net margin of 31.71% compared to Polar Capital Global Financials Trust's net margin of 0.00%. Maven Income and Growth VCT 4's return on equity of 1.48% beat Polar Capital Global Financials Trust's return on equity.Company Net Margins Return on Equity Return on Assets Maven Income and Growth VCT 431.71% 1.48% -0.11% Polar Capital Global Financials Trust N/A N/A N/A SummaryMaven Income and Growth VCT 4 beats Polar Capital Global Financials Trust on 4 of the 7 factors compared between the two stocks. Get Maven Income and Growth VCT 4 News Delivered to You Automatically Sign up to receive the latest news and ratings for MAV4 and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MAV4 and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAV4 vs. The Competition Export to ExcelMetricMaven Income and Growth VCT 4Asset Management IndustryFinancial SectorLON ExchangeMarket Cap£79.26M£1.20B£5.64B£2.91BDividend Yield6.76%4.34%4.13%4.90%P/E Ratio59.5521.4612.63124.60Price / Sales18.892,411.701,724.55248,064.90Price / Cash3.0760.8149.9228.07Price / Book0.851.163.154.64Net Income£1.33M£264.77M£1.23B£5.91B7 Day PerformanceN/A11.90%5.93%12.86%1 Month Performance-3.57%29.66%15.28%25.97%1 Year Performance-5.26%5.33%14.63%77.95% Maven Income and Growth VCT 4 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAV4Maven Income and Growth VCT 4N/AGBX 54-1.8%N/A-3.6%£79.26M£4.20M59.55N/APCFCPolar Capital Global Financials TrustN/AN/AN/AN/A£315.13M£70.33M2.09N/AEATEuropean Assets TrustN/AGBX 87.40+0.9%N/A-2.9%£314.33M£35.04M11.25N/AHHIHenderson High Income TrustN/AGBX 181+0.8%N/A+11.6%£312.78M£39.56M9.19N/APositive NewsHigh Trading VolumeJPSJPMorgan Japan Small Cap Growth & Income plc (JPS.L)N/AN/AN/AN/A£305.80M-£1.02M-48.36N/AWPCTWoodford Patient Capital TrustN/AN/AN/AN/A£305.30M£56.03M5.33N/ANCYFCQS New City High YieldN/AGBX 51.20+0.4%N/A+1.2%£300.91M£53.40M6.43N/ABGHSBoussard & Gavaudan GBPN/AN/AN/AN/A£300.90M-£12.39M-1,890.63N/AGap UpGSEOVH Global Sustainable Energy OpportunitiesN/AGBX 67.60-0.3%N/A-9.1%£300.89M£28.19M16.26N/ASTSSTS Global Income & Growth TrustN/AGBX 245+0.4%N/A+9.7%£300.09M£20.58M16.346Positive NewsBBHBellevue HealthcareN/AGBX 120.40+0.8%N/A-12.6%£296.74M-£9.60M-18.31N/ANews Coverage Related Companies and Tools Related Companies PCFC Alternatives EAT Alternatives HHI Alternatives JPS Alternatives WPCT Alternatives NCYF Alternatives BGHS Alternatives GSEO Alternatives STS Alternatives BBH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MAV4) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maven Income and Growth VCT 4 PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Maven Income and Growth VCT 4 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAV4 Stock Free MAV4 Stock Alerts